Longeveron annual ebitda
2020
2021
2022
2023
2024
2025
Longeveron EBITDA Growth & History (LGVN)
Longeveron's calculated EBITDA was −$22.5M for fiscal 2025.
View full Longeveron company overviewLongeveron annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$22.5M | −$6.7M | — |
| 2024 | 2024-12-31 | −$15.8M | $4.5M | — |
| 2023 | 2023-12-31 | −$20.3M | −$3.0M | — |
| 2022 | 2022-12-31 | −$17.3M | $112,999.3 | — |
| 2021 | 2021-12-31 | −$17.5M | −$13.7M | — |
| 2020 | 2020-12-31 | −$3.8M | — | — |
Longeveron quarterly ebitda
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$6.0M | −$774,000 | — |
| Q1 2026 | 2026-03-31 | −$4.6M | $406,000 | — |
| Q4 2025 | 2025-12-31 | −$5.2M | −$1.0M | — |
| Q3 2025 | 2025-09-30 | −$7.1M | −$2.7M | — |
| Q2 2025 | 2025-06-30 | −$5.2M | −$1.9M | — |
| Q1 2025 | 2025-03-31 | −$5.0M | −$1.1M | — |
| Q4 2024 | 2024-12-31 | −$4.2M | $1.2M | — |
| Q3 2024 | 2024-09-30 | −$4.4M | $512,000 | — |
| Q2 2024 | 2024-06-30 | −$3.3M | $2.2M | — |
| Q1 2024 | 2024-03-31 | −$3.9M | $626,000 | — |
| Q4 2023 | 2023-12-31 | −$5.3M | −$299,000 | — |
| Q3 2023 | 2023-09-30 | −$5.0M | $26,000 | — |
| Q2 2023 | 2023-06-30 | −$5.5M | −$1.5M | — |
| Q1 2023 | 2023-03-31 | −$4.5M | −$1.2M | — |
| Q4 2022 | 2022-12-31 | −$5.0M | −$510,000.7 | — |
| Q3 2022 | 2022-09-30 | −$5.0M | −$282,000 | — |
| Q2 2022 | 2022-06-30 | −$4.0M | $941,000 | — |
| Q1 2022 | 2022-03-31 | −$3.3M | −$36,000 | — |
| Q4 2021 | 2021-12-31 | −$4.5M | −$2.6M | — |
| Q3 2021 | 2021-09-30 | −$4.7M | −$3.9M | — |
| Q2 2021 | 2021-06-30 | −$5.0M | −$3.9M | — |
| Q1 2021 | 2021-03-31 | −$3.3M | −$3.2M | — |
| Q4 2020 | 2020-12-31 | −$2.0M | — | — |
| Q3 2020 | 2020-09-30 | −$760,000 | — | — |
| Q2 2020 | 2020-06-30 | −$1.0M | — | — |
| Q1 2020 | 2020-03-31 | −$13,000 | — | — |
Longeveron ebitda trends
Over the last five fiscal years, Longeveron's ebitda decreased from −$3.8M to −$22.5M, a change of −$18.7M. The latest reported quarter, Q2 2026, shows −$6.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Longeveron source filings ↗Community posts
Longeveron’s infant heart-disease trial misses its primary endpoint
Longeveron ($LGVN) said its ELPIS II Phase 2b study in infants with hypoplastic left heart syndrome failed to meet its primary endpoint. The 40-patient trial assessed right-ventricular function after 12 months. The reported treatment differ ...
